19th European Urology
Residents Education Programme
Registration information

Static homepage

Due to uncertainties brought about by the COVID-19 situation, we have made the difficult but important decision to postpone EUREP which was planned for 3 to 8 September 2021 to 4 to 9 February 2022 instead.

Dear future European urologists

On its second successful decade as a comprehensive course, the European Urology Residents Education Programme (EUREP) continues to be a reputable and educative programme for final-year residents.

Organised by the European School of Urology, EUREP is designed to offer a significant overview of urological topics with a high-degree of interaction and brainstorming. Its five modules consist of mornings reserved for state-of-the-art lectures and the afternoons for discussions, videos and test-your-knowledge sessions.

Read more

Dr Evangelos Liatsikos

E. Liatsikos
Chairman ESU

Why you should attend this meeting

Extensive coverage

The EUREP programme is always wide-ranged and dynamic, covering almost the whole spectrum of urology in 6 intensive days; from onco-urology, functional urology, andrology, to paediatric urology.

Best practices and expert faculty

The internationally-known EUREP faculty will guide delegates in modules designed to enrich knowledge and skills, boost daily clinical practice, and address commonly-faced challenges.

Excellent career opportunities

EUREP opens new doors and possibilities for urology residents  that benefit their professional careers, and expand their connections.

News & Reports

European School of Urology on Twitter

Endoscopic stone treatment (EST) step 2 is here. 4 years of hard work and collaborative work with sections and friends. @d_veneziano @Aploumidis1 @AliSerdarGozen @joanfundi @drkemalsarica @evanliats @kahmed198 @guimaaka @TheodorosTokas @UrowebESU @eauesut @eulis_uroweb @Uroweb

(3/3) Prof. @paolo_gontero: "In metastatic cases, high cure rates are achievable through multimodal tailored administration of chemo, surgical resection and radiotherapy (when indicated) by experts within a multidisciplinary team."


(2/3) Prof. @paolo_gontero: "In non-metastatic cases, available adjuvant treatment options must be carefully weighted with their long-term toxicity profile. AS should be prioritised whenever possible due to the high-cure rate of salvage therapies."


Load More...